Companies/Allarity Therapeutics A/S
Follow

Allarity Therapeutics A/S

Allarity Therapeutics is a late clinical-stage, precision medicine company actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers guided by its proprietary drug response predictor technology, the DRP platform.
Go to market

Sector:
HEALTH CARE
>
Biotechnology
Healthcare
Media
Showing 3 of 5
View all
www.allarity.com
Status
This company has been delisted, therefore no further market information will be available.
Top
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived

NB! Information about past events and all documents are available for signed in users who have bought those events.

Type
Ticker
ISIN
Market
SHARE
ALLR
DK0060732477
Details of share in Allarity Therapeutics A/S with ticker ALLR
Status
Delisted
Amount of instruments
191 754 351
Currency
SEK
Listing
Sign in to buy
Rights issue
Sign in to buy
Private placement
Sign in to buy
Rights issue
Sign in to buy
Rights issue
Sign in to buy
Exercise
Sign in to buy
Rights issue
Sign in to buy
Debt conversion
Sign in to buy
Exercise
Sign in to buy
Debt conversion
Sign in to buy
Convertible issue
Sign in to buy
Convertible issue
Sign in to buy
Directed issue
Sign in to buy
Convertible issue
Sign in to buy
Set-off issue
Sign in to buy
Convertible issue
Sign in to buy
Convertible issue
Sign in to buy
Directed issue
Sign in to buy
Directed issue
Sign in to buy
Rights issue
Sign in to buy
Remuneration issue
Sign in to buy
Exercise
Sign in to buy
Delisting
Sign in to buy
Type
Ticker
ISIN
Market
SHARE
MPI
DK0060514487
Nasdaq First North GM Copenhagen
Denmark (DK)
Details of share in Allarity Therapeutics A/S with ticker MPI
Status
Archived
Amount of instruments
—
Currency
DKK
Listing
Sign in to buy
Rights issue
Sign in to buy
Private placement
Sign in to buy
Rights issue
Sign in to buy
Type
Ticker
ISIN
Market
SHARE
OV
DK0060732477
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in Allarity Therapeutics A/S with ticker OV
Status
Archived
Amount of instruments
191 754 351
Currency
SEK
Rights issue
Sign in to buy
Rights issue
Sign in to buy
Debt conversion
Sign in to buy
Debt conversion
Sign in to buy
Convertible issue
Sign in to buy
Convertible issue
Sign in to buy
Directed issue
Sign in to buy
Convertible issue
Sign in to buy
Set-off issue
Sign in to buy
Convertible issue
Sign in to buy
Convertible issue
Sign in to buy
Directed issue
Sign in to buy
Type
Ticker
ISIN
Market
SHARE
ALLR
DK0060732477
Details of share in Allarity Therapeutics A/S with ticker ALLR
Status
Delisted
Amount of instruments
191 754 351
Currency
SEK
Directed issue
Sign in to buy
Rights issue
Sign in to buy
Remuneration issue
Sign in to buy
Delisting
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
OV TO 1
DK0061139581
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in Allarity Therapeutics A/S with ticker OV TO 1
Status
Archived
Amount of instruments
20 166 221
Currency
SEK
Trading period
24 Jul 2019 - 22 May 2020
Terms
One (1) investor warrant entitles the holder to subscribe for one (1) new share in the Company.
Exercise
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
ALLR TO2
DK0061153657
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in Allarity Therapeutics A/S with ticker ALLR TO2
Status
Archived
Amount of instruments
50 341 080
Currency
SEK
Trading period
04 Feb 2020 - 13 Sep 2021
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share in the Company.
Exercise
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
ALLR TO3
DK0061552270
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in Allarity Therapeutics A/S with ticker ALLR TO3
Status
Archived
Amount of instruments
145 003 680
Currency
SEK
Trading period
06 Jul 2021 - 09 Sep 2021
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share in the Company for SEK 1.70 in a period of up to twenty-four (24) months following the Rights issue.
Update (26.08.2021): Extraordinary exercise reriod for warrants TO3.
Update (27.08.2021): New Extraordinary Exercise Period for Allarity Therapeutics series TO3.
Exercise
Sign in to buy
People
Steve Carchedi
CEO
Duncan Moore
Chairman of the board
Gail Maderis
Board member
Søren Gade
Board member
Steve Carchedi
Board member
Company Details
Sector
HEALTH CARE
Website
Address
Venlighedsvej 1
Zip code
2970
City/district
Hørsholm
Country
Denmark (DK)
Phones
Email
[email protected]
Registration number
28106351
LEI code
213800FKAPK1MPJ18Q79
First trade date
22 Jul 2015
Company former names
Oncology Venture A/S
12 Oct 2020
Medical Prognosis Institute A/S
03 Sep 2018
Registration date
09 Sep 2004
Short name
ALLR

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More